Japan Nutrigenomics Market

Japan Nutrigenomics Market Insights Forecasts to 2035

• The Japan Nutrigenomics Market Size Was Estimated at USD 108.4 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 13.76% from 2025 to 2035
• The Japan Nutrigenomics Market Size is Expected to Reach USD 447.5 Million by 2035

According to a research report published by Decision Advisor & Consulting, The Japan Nutrigenomics Market Size is anticipated to reach USD 447.5 Million by 2035, Growing at a CAGR of 13.76% from 2025 to 2035. The market is driven by demand for personalized nutrition will continue to rise due to an increasing number of disease cases caused by unhealthy lifestyles, and consumers’ greater understanding of how their genetics affects their diet and health. Other factors that are contributing to the continued growth of the personalized nutrition market include the development of genomic technology, the implementation of Artificial Intelligence into nutrition platforms, and increased partnerships among healthcare providers, biotechnology companies, and wellness-related firms.

Market Overview

The Japan nutrigenomics market refers to the research and development, and commercialization of products and services that study how genes interact with nutrition and health outcomes. Innovating in the field of nutritional genomics requires understanding how a person's genetic differences affect nutrient absorption, metabolism, and how that person responds to dietary interventions, in order to develop personalized nutritional interventions. The main trends are the increased usage of direct-to-consumer genetic testing kits, the growth of AI-based dietary recommendation platforms, and the increasing demand for personalized supplements. Characteristics of the Market are a heavy dependence on genomic data, extensive use of digital health technology, and an intense focus on preventive health. The Key Market Drivers are the increasing number of consumer lifestyle disorders, the increased population of older people, and the increased demand for personalized health delivery options.

Japan government, such as the funding of genomic research, assistance with precision medicine, and the digital transformation of health care. The Ministry of Health, Labour and Welfare (MHLW) promotes the use of preventive health care and personalized medicine. In addition, Japan's government is supporting the development of nutrigenomics and population-based health optimisation through its national genome research initiatives.

Report Coverage

This research report categorizes the market for the Japan nutrigenomics market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan nutrigenomics market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan nutrigenomics market.

Driving Factors

The Japanese nutrigenomics market is driven by growing consumer interest in personalized nutrition, combined with the increasing rates of obesity, diabetes, and cardiovascular disease, as well as the growing preference for preventive health care options continue to fuel the market growth of personalized nutrition products. The support of advances in genetic sequencing technologies, Integration of Artificial Intelligence with digital health platforms, and the continued availability of DTC genomic testing kits have resulted in a large increase in market growth. Also supporting the market growth of personalized nutrition products is the government initiatives in promoting precision medicine and supporting a growing trend towards adopting wellness-focused lifestyles.

Restraining Factors

The Japanese nutrigenomics market is restrained by gene testing and personalized nutrition because of high costs. Consumer concerns about the privacy of their data may hinder the adoption of gene testing, and limited consumer understanding of their genetic results, as well as the absence of standard regulations for DNA testing for nutritional considerations, will slow down the adoption process. In addition to these limitations in the market place there are also reimbursement limitations regarding the reimbursement for nutritional counseling based upon genetic testing data.

Market Segmentation

The Japan nutrigenomics market share is categorized by product type and application.

• The reagents and kits segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan nutrigenomics market is segmented by product type into reagents and kits, and services. Among these, the reagents and kits segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment is driven by the essential role that testing kits and biochemical reagents play in enabling genetic analysis for personalized nutrition. Reagents and kits such as DNA extraction kits and genotyping assays form the backbone of nutrigenomics testing platforms, and their widespread adoption in research labs, hospitals, and direct-to-consumer offerings continues to drive growth.

• The obesity application segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan nutrigenomics market is segmented by application into obesity, cardiovascular diseases, cancer research, and other applications. Among these, the obesity segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment is driven by increasing rates of obesity and metabolic disorders in Japan, elevated demand for personalized dietary insights, and gene-based nutritional interventions. Nutrigenomics tools help tailor diet plans to genetic predispositions, making them valuable for obesity management and preventive health strategies.

• The saliva technique segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan nutrigenomics market is segmented by technique into buccal swab, blood, and saliva. Among these, the saliva segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment is driven by its non-invasive, user-friendly nature, which allows consumers to provide samples comfortably without clinic visits. Saliva-based nutrigenomic tests are widely used in both clinical settings and direct-to-consumer genetic testing programs, boosting their adoption in Japan.

• The hospitals & clinics segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan nutrigenomics market is segmented by distribution channel into hospitals & clinics and online platforms. Among these, the hospitals & clinics segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment is driven by healthcare providers increasingly integrate nutrigenomics testing into clinical practice for chronic disease management and preventive nutrition counseling. Online platforms are also gaining traction due to convenience and rising consumer demand for at-home testing solutions.

Competitive Analysis

The report offers the appropriate analysis of the key organizations/companies involved within the Japan nutrigenomics market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• GeneLife Inc.
• GeneticLab Co., Ltd.
• Nippon Suisan Kaisha, Ltd.
• Fancl Corporation
• Kao Corporation
• Ajinomoto Co., Inc.
• Nestlé Japan
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting and Research Firms
• Venture Capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In February 2025, Gene Life Inc. launched an AI-powered nutrigenomics platform in Japan that provides personalized dietary and supplement recommendations based on genetic profiles and lifestyle data.

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Decision Advisor has segmented the Japan Nutrigenomics Market based on the below-mentioned segments:

Japan Nutrigenomics Market, By Product Type

• Reagents and Kits
• Services

 Japan Nutrigenomics Market, By Application

• Obesity
• Cardiovascular Diseases
• Cancer Research
• Other

Japan Nutrigenomics Market, By Technique

• Buccal Swab
• Blood
• Saliva

Japan Nutrigenomics Market, By Distribution Channel

• Hospitals & Clinics
• Online Platforms

Frequently Asked Questions (FAQ’s)

Q: What is the Japan Nutrigenomics Market size?

A: Japan Nutrigenomics Market size is expected to grow from USD 108.4 million in 2024 to USD 447.5 million by 2035, growing at a CAGR of 13.76% during the forecast period 2025 to 2035.

Q: What are the key growth drivers of the market?

A: Market growth is driven by rising demand for personalized nutrition, increasing lifestyle-related diseases, and government support for precision medicine.

Q: What factors restrain the Japan Nutrigenomics Market?

A: High testing costs, data privacy concerns, limited reimbursement, and lack of standardized regulations.

Q: Who are the key players in the Japan Nutrigenomics Market?

A: Key companies include GeneLife Inc., Fancl Corporation, Ajinomoto Co., Kao Corporation, and others.